Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Bindley Capital Partners I, LLC - 20 Mar 2026 SCHEDULE 13D/A Report for Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share (GRDN)
- Filing manager
- Bindley Capital Partners I, LLC
- Reporting owner
- Thomas J. Salentine, Jr.
- Beneficially owned shares
- 10,605,205 shares
- Large-stake signal
-
Ownership
21%Beneficial ownership of this reported class.
Shares
10,605,205 sharesShares beneficially owned as disclosed.
Event date
20 Mar 2026Date tied to the ownership event or amendment.
Accepted by SEC
24 Mar 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 21%
- Symbol
- GRDN
- Shares outstanding
- 49,789,695 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 24 Mar 2026, 18:17:38 UTC
- Event date
- 20 Mar 2026
- Prior SEC filing
- 29 Jul 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Bindley Capital Partners I, LLC disclosed 21% ownership in Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share (GRDN) on 20 Mar 2026.
Key facts
- Bindley Capital Partners I, LLC filed SCHEDULE 13D/A for Guardian Pharmacy Services, Inc. Class A Common Stock, par value $0.001 per share (GRDN).
- Disclosed ownership: 21%.
- Date of event: 20 Mar 2026.
Change
- Previous schedule filing date: 29 Jul 2025.
- Current filing was accepted on 24 Mar 2026, 18:17.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (9)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bindley Capital Partners I, LLC | 21% | 10,569,491 | 10,569,491 | 0 | /s/ Thomas J. Salentine, Jr. | Member | 0002038820 |
| William E. Bindley | 21% | 10,569,491 | 0 | 10,569,491 | /s/ William E. Bindley, individually | William E. Bindley, individually | 0000903539 |
| Thomas J. Salentine, Jr. | 21% | 10,605,205 | 35,714 | 10,569,491 | /s/ Thomas J. Salentine, Jr., individually | Thomas J. Salentine, Jr., individually | 0002037899 |
| Pharmacy Investors, LLC | 4.9% | 2,449,867 | 2,449,867 | 0 | /s/ John Ackerman | Managing Member | 0002038519 |
| John Ackerman | 4.9% | 2,449,867 | 2,449,867 | 0 | /s/ John Ackerman, individually | John Ackerman, individually | 0002037898 |
| Cardinal Equity Fund, L.P. | 1.6% | 816,180 | 816,180 | 0 | /s/ John Ackerman, by Cardinal Equity Partners, LLC, its General Partner | Managing Member | 0001432819 |
| Fred P. Burke | 4.3% | 2,139,240 | 2,139,240 | 0 | /s/ Fred P. Burke, individually | Fred P. Burke, individually | 0002037972 |
| David K. Morris | 1.8% | 877,004 | 877,004 | 0 | /s/ David K. Morris, individually | David K. Morris, individually | 0002037977 |
| G. Kendall Forbes | 2.1% | 1,042,489 | 1,042,489 | 0 | /s/ G. Kendall Forbes, individually | G. Kendall Forbes, individually | 0002038507 |
CIK / CUSIP context first